Polymyalgia rheumatica (PMR) is characterised by pain and stiffness in the shoulder and pelvic girdles, accompanied by a pronounced acute phase response. Although its cause is unknown, genetic factors may have a role, as suggested by reports offamilial clustering1 and the association with the HLA antigen DR4.2 Hepatitis B virus has occasionally been proposed as a triggering agent,3 but this observation has not been confirmed in other series. 4 As PMR is often heralded by acute and severe symptoms most patients can recall exactly the date of onset. A seasonal clustering of cases of PMR in both summer and winter was described by Mowat and Hazlemans and confirmed by Bird et al. 6 On the other hand, two other more recent reports failed to show any seasonal trend. May to August the incidence of PMR was significantly higher than in the other months (36 new cases vs 22; X2=22-49; p<0-0001). No differences were found in this seasonal pattern when the data were broken down by the different rheumatological clinics or by the year of onset (data not shown). patients' first visit, which was roughly even throughout the year (between the four month periods January to April, May to August, and September to December x2=3 34; NS). There was a significant difference between the two distributions (p<0 02), excluding the possible bias of selective referral of this type of patient in a given period of the year. Figure 3 shows the mean monthly temperatures and hours of sunshine. The mean temperature from May to August was more than twice that during the remaining months. The differences in the number of monthly sunshine hours were also pronounced. The monthly incidence of PMR was significantly correlated with the mean temperatures (p<005) and hours of sunshine (p=0 01).
The 36 patients with onset of disease from May to August were compared with the remaining 22 patients in terms of clinical signs and symptoms, treatment, and ESR. No significant differences were found, although the male to female ratio, the mean ESR, and the percentage of patients with fever or weight loss were slightly higher in the 'May to August' group. Conversely, prevalence of temporal arteritis was slightly lower in the patients with summer onset: (five/36; 13 9%) compared with the remaining patients (five/22; 2277%, NS).
Forty four out of 80 (55%) patients with EORA could recall the month of onset of their symptoms. This percentage was significantly lower (X2 =9-2; p<001) than that of the patients with PMR who could do the same (79%). The onset of symptoms in 44 patients with EORA, including those with polymyalgia-like attacks, was scattered throughout the year with no seasonal clustering (fig 4) . Thirty one per cent of the patients with EORA traced the onset of their symptoms to the four months from May to August compared with 62% of the patients with PMR (x2 =799%; p<0-01). A seasonal pattern in the incidence of a disease of unknown origin may be helpful in that it points to agents which usually display seasonal variations.'0 The summer clustering of new cases of PMR may be related to causes such as higher outside temperatures or increased exposure to sunlight. " Solar radiation, mainly of the infrared type, may disrupt the internal elastic lamina of medium and small sized vessels, inducing the expression ofnew antigenic determinants.'2 This vascular damage could be the common pathogenetic mechanism for both the synovitis of PMR and temporal arteritis. The onset of temporal arteritis is characterised by a well defined summer peak, as shown by Kinmont and McCallum.'3 In our series, however, the number of patients with temporal arteritis was too small to show any seasonal pattern of onset. Alternatively, exposure to sunlight may be a triggering factor by its possible interference with the immunological response.'4 The OKT8+ suppressor/cytotoxic subset of T cells, however, increases when healthy volunteers are exposed to artificial actinic radiation in a solarium. 4 As a result, this feature cannot be considered to be typical of patients with PMR in whom a selective defect of the OKT8+ suppressor/cytotoxic subset of T cells has been described. '5 16 Exposure Seasonality may prove useful in the differential diagnosis between PMR and EORA, which is often difficult in the early stages. In our series the onset occurred from May to August in 62% of patients with PMR compared with 31% of patients with EORA (p<0-01). Thus when the standardisation by yearly incidence of the diseases is considered, an inflammatory syndrome affecting mainly the pelvic or shoulder girdles and beginning in the summer months is more likely to be PMR than EORA.
In conclusion, a seasonal onset of PMR has been shown in three different series of outpatients in northern Italy. This may point to a few agents for this disease of unknown origin which share this seasonality. Further studies to examine selectively some behavioural patterns, such as exposure to sunlight and sun sensitising drugs, in patients with PMR could be of interest. Likewise, serological investigations into possible exposure to specific infective agents might also be useful.
